0001179110-17-012027.txt : 20170905
0001179110-17-012027.hdr.sgml : 20170904
20170905193209
ACCESSION NUMBER: 0001179110-17-012027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170831
FILED AS OF DATE: 20170905
DATE AS OF CHANGE: 20170905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malkani Sanjay
CENTRAL INDEX KEY: 0001571523
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 171069971
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD, SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
4
1
edgar.xml
FORM 4 -
X0306
4
2017-08-31
0
0001145460
ALERE INC.
ALR
0001571523
Malkani Sanjay
51 SAWYER ROAD, SUITE 200
WALTHAM
MA
02453
0
1
0
0
Global Pres., Toxicology
Common Stock
2017-08-31
4
M
0
6667
A
30795
D
Common Stock
2017-08-31
4
F
0
2038
49.46
D
28757
D
Common Stock
565
I
See footnote 4.
Restricted Stock Units
2017-08-31
4
M
0
6667
0
D
Common Stock
6667
0
D
Each restricted stock unit represents a contingent right to receive one share of Alere common stock.
On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17).
These securities are owned by the reporting person's spouse.
The reporting person hereby disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16.
/s/ Douglas Barry, Attorney-in-Fact
2017-09-05